robenacoxib 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| selective cyclo-oxygenase inhibitors | 5612 | 220991-32-2 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
|
Drug dosage:
None
ADMET properties:
None
Approvals:
| Date | Agency | Company | Orphan |
|---|---|---|---|
| None | FDA |
FDA Adverse Event Reporting System (Female)
None
FDA Adverse Event Reporting System (Male)
None
FDA Adverse Event Reporting System (Geriatric)
None
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
| Source | Code | Description |
|---|---|---|
| CHEBI has role | CHEBI:35475 | non-steroidal anti-inflammatory agent |
| CHEBI has role | CHEBI:50629 | COX-2 inhibitor |
Drug Use | Suggest Off label Use Form| |View source of the data|
None
🐶 Veterinary Drug Use
| Species | Use | Relation |
|---|---|---|
| Cats | Postoperative pain and inflammation associated with orthopedic surgery | Indication |
| Cats | Ovariohysterectomy | Indication |
| Cats | Castration | Indication |
🐶 Veterinary products
| Product | Applicant | Ingredients |
|---|---|---|
| onsior Tablets for Cats | Elanco US Inc. | 1 |
| onsior injection | Elanco US Inc. | 1 |
| onsior | Elanco US Inc. | 1 |
Acid dissociation constants calculated using MoKa v3.0.0
None
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
None
External reference:
| ID | Source |
|---|---|
| CHEBI:76269 | CHEBI |
| CHEMBL2107774 | ChEMBL_ID |
| C551524 | MESH_SUPPLEMENTAL_RECORD_UI |
| DB11455 | DRUGBANK_ID |
| 017823 | NDDF |
| C2825257 | UMLSCUI |
| 8352 | INN_ID |
| C20708 | KEGG_DRUG |
| 6433107 | PUBCHEM_CID |
| 1250203 | RXNORM |
| Z588009C7C | UNII |
Pharmaceutical products:
None